Cell Cycle
-
CDK9 inhibitor 2
Catalog No. A15039 -
AT7519 trifluoroacetate
Catalog No. A15005 CDK 抑制剂AT7519 trifluoroacetate是CDK1、2、4、6和9的多CDK抑制剂,IC50为10-210 nM,对CDK3的效力较低,对CDK7的活性较低。 了解更多 -
RGB-286638
Catalog No. A13130 CDK 抑制剂RGB-286638是一种新型CDK抑制剂,对于细胞周期蛋白T1-CDK9/细胞周期蛋白B1-CDK1/细胞周期蛋白E-CDK2/细胞周期蛋白D1-CDK4/细胞周期蛋白E-CDK3的IC50为1 nM/2 nM/3 nM/4 nM/5 nM/p35-CDK5分别;对细胞周期蛋白H-CDK7和细胞周期蛋白D3-CDK6的效力较低。 了解更多 -
Bohemine
Catalog No. A15942 -
LY2835219 methanesulfonate
Catalog No. A16386 -
SB1317 (TG02)
Catalog No. A13454 CDK/JAK2/FLT3 抑制剂SB1317是细胞周期蛋白依赖性激酶(CDKs)、类FMS酪氨酸激酶-3(FLT3)和Janus激酶2(JAK2)的有效抑制剂,CDK2、JAK2和FLT3的IC50值分别为13nM、56nM和73nM。 了解更多 -
Atuveciclib (BAY-1143572)
Catalog No. A16810 Selective PTEFb/CDK9 抑制剂Atuveciclib (BAY-1143572)是目前处于I期的PTEFb/CDK9的高度选择性,有效且可口服的抑制剂。 了解更多 -
ICEC0942 HCl
Catalog No. A16903 CDK7 抑制剂ICEC0942 HCl,也称为CT7001,是CDK7的口服生物利用选择性抑制剂。它选择性抑制CDK7,IC50为40nM。CDK1,CDK2,CDK5和CDK9的IC50值分别高45倍,15倍,230倍和30倍。 了解更多 -
PF-06873600
Catalog No. A16875 CDK 抑制剂PF-06873600是一种口服生物利用型,细胞周期蛋白依赖性激酶(CDK)抑制剂,其对 CDK2、CDK4和CDK6的Ki值分别为 0.09 nM、0.13 nM 和 0.16 nM。具有潜在的抗肿瘤活性。 了解更多 -
SEL120-34A
Catalog No. A17086 -
Trilaciclib
Catalog No. A17084 -
Lerociclib (G1T38)
Catalog No. A18320 CDK inhibitorLerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 1 nM, 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively. 了解更多 -
CDK4/6-IN-2
Catalog No. A18657 CDK4/CDK6 inhibitorCDK4/6-IN-2 is a potent CDK4 and CDK6 inhibitor with IC50s of 2.7 and 16 nM for CDK4 and CDK6, respectively. 了解更多 -
THAL-SNS-032
Catalog No. A19088 CDK9 degrader PROTACTHAL-SNS-032 is a selective CDK9 degrader PROTAC consisting of a CDK-binding SNS-032 ligand linked to a thalidomide derivative that binds the E3 ubiquitin ligase Cereblon (CRBN). 了解更多 -
FMF-04-159-2
Catalog No. A18911 CDK14 inhibitorFMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively. 了解更多 -
Abemaciclib Metabolites M2
Catalog No. A18416 CDK4/CDK6 inhibitorAbemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s in the range of 1-3 nM. Anti-cancer activity. 了解更多 -
MSC2530818
Catalog No. A12644 CDK8 inhibitorMSC2530818 is a potent, selective and orally available CDK8 inhibitor with an IC50 of 2.6 nM for CDK8. 了解更多 -
Ca2+ channel agonist 1
Catalog No. A12186 Ca2+ channel agonist/CDK2 inhibitorCa2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2, with EC50s of 14.23 μM and 3.34 μM, respectively, and is used as a potential treatment for motor nerve terminal dysfunction. 了解更多 -
LEE011 (Ribociclib)
Catalog No. A13549 CDK4/6 抑制剂LEE011 (Ribociclib)是一种可口服的细胞周期蛋白依赖性激酶(CDK)抑制剂,靶向细胞周期蛋白D1/CDK4和细胞周期蛋白D3/CDK6细胞周期途径,具有潜在的抗肿瘤活性。 了解更多 -
AMG-925
Catalog No. A14025 -
Purvalanol A
Catalog No. A15517 CDK 抑制剂Purvalanol A是一种有效的细胞渗透性细胞周期蛋白依赖性蛋白激酶(cdk)抑制剂。对于cdc2/cyclin B,cdk2/cyclin A,cdk2/cyclin E,cdk4/cyclin D1和cdk5-p35,IC50值分别为4、70、35、850和75 nM。 了解更多 -
NVP-LCQ195
Catalog No. A15196 -
AG-024322
Catalog No. A15485 -
NU2058
Catalog No. A15767 -
Senexin A
Catalog No. A21166 -
Voruciclib hydrochloride
Catalog No. A21385 CDK inhibitorVoruciclib hydrochloride is a clinical stage orally active and selective CDK inhibitor with Ki values of 0.626 nM-9.1 nM. 了解更多 -
PHA-767491 hydrochloride
Catalog No. A21395 dual Cdc7/Cdk9 inhibitorPHA-767491 hydrochloride is a dual Cdc7/Cdk9 inhibitor, with IC50s of 10 nM and 34 nM, respectively. 了解更多 -
(±)-BAY-1251152
Catalog No. A21564 PTEF/CDK9 inhibitor(±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. 了解更多